Everything below concerns DAC linker. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-12-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
During Bryson's 20-month tenure as Lilly's president and CEO, the company reported its first quarterly loss as a publicly traded company. In 1993, Randall L. Tobias, vice chairman of AT&T Corporation and a Lilly board member, was named Lilly's chairman, president, and CEO, the first president and CEO recruited from outside of the company. In 1994, Lilly separated its medical device division. It also acquired PCS Systems, the largest drug benefits health maintenance organization at the time, for $4 billion. Released in 1996, Zyprexa (Olanzapine) (for schizophrenia and bipolar disorder, as well as off-label uses) (see Illegal marketing of Zyprexa) was the company's best-selling drug through 2010, when the patent expired. In May 1996, the Food and Drug Administration approved gemcitabine (Gemzar) for the treatment of pancreatic cancer. Gemzar is commonly used in the treatment of pancreatic cancer, usually in coordination with 5-FU chemotherapy and radiation therapy. Gemzar is also routinely used to treat non-small cell lung cancer. In 1998, the company dedicated new laboratories for clinical research at the Indiana University Medical Center in Indianapolis. Sidney Taurel, former chief operating officer of Lilly, was named CEO in July 1998 to replace Tobias, who retired. Taurel became chairman of the board in January 1999. Taurel retired as CEO in March 2008, but remained as chairman of the board until 31 December 2008. John C. Lechleiter was elected as Lilly's CEO and president, effective 1 April 2008.
A Dyson tree is a hypothetical genetically engineered plant (perhaps resembling a tree) capable of growing inside a comet, suggested by the physicist Freeman Dyson. Plants may be able to produce a breathable atmosphere within the hollow spaces of the comet (or maybe even within the plants themselves), utilising solar energy for photosynthesis and cometary materials for nutrients, thus providing self-sustaining habitats for humanity in the outer solar system analogous to a greenhouse in space, a shell grown by a mollusc or the actions of thermogenic plants, such as the skunk cabbage or the voodoo lily. A Dyson tree might consist of a few main trunk structures growing out from a comet nucleus, branching into limbs and foliage that intertwine, forming a spherical structure possibly dozens of kilometers across.
Zipline originated from Romotive, a company founded in 2011 by Keller Rinaudo Cliffton that produced an iPhone-controlled robot. Romotive ceased operations in 2014, after which Rinaudo, Ryan Oksenhorn, William Hetzler, and Keenan Wyrobek began developing a fixed-wing drone platform intended for medical delivery. This effort became the basis for Zipline. The company began operations in Rwanda in October 2016 following a government agreement to deliver blood and medical supplies to rural clinics from a centralized distribution center. A second Rwandan center opened in 2018 as the scope of deliveries expanded to include routine vaccines and essential medicines. Zipline launched operations in Ghana on April 24, 2019 under a government contract that provided drone delivery services to public-sector health facilities. The program later expanded to multiple distribution centers serving additional regions. Beginning in 2020, the company participated in regulatory programs, including the FAA type-certification process for delivery drones in the United States. It also deployed temperature-controlled payload systems to support delivery of vaccines requiring cold-chain conditions, including during COVID-19 vaccination campaigns in parts of Africa. From 2022 onward, Zipline initiated operations outside Africa, including a partner-operated distribution center in Japan and limited pilot projects in the United States. It also introduced a new platform aimed at home deliveries in denser urban and suburban environments.
== Biomarkers of reproductive health == The main neohormones that can be used as biomarkers of reproductive health are relaxin, oxytocin, hCG, INSL3, and INSL5 and INSL6. Relaxin (Specifically Ovarian H2-relaxin) aids in the implantation of the embryo into the uterine wall after fertilisation, as well as establishing the placenta. The levels of relaxin are altered in cases of early miscarriage and hence can be used as a biomarker during early pregnancy. Oxytocin has a range of functions in the reproductive systems of both males and females. It has a major role in the production of breast milk and lactation. It is responsible for muscle contractions in the uterus to facilitate birth. It also assists in ovarian steroid production and ovum release. In men, oxytocin has a role in erections and ejaculation. It also participates in gonadal development in both males and females. Despite being tricky to measure, measuring oxytocin can help build a clinical picture of reproductive health in the above mechanisms. hCG has a vital role in early pregnancy. Higher levels of hCG is a good indication for the survival and viability of the embryo. β-hCG can be monitored to test for an ectopic pregnancy. INSL3 is responsible for the first phase of testicular descent in males and may be disrupted in cases of cryptorchidism. It also acts as a measure of Leydig cell function, particularly in older males. INSL5 and INSL6 may have a role in spermatogenesis.
== Commercial and industrial use == PABA finds use in the biomedical sector. Its derivatives are found as a structural component in 1.5% of a database of 12111 commercial drugs. Other uses include its conversion to specialty azo dyes and crosslinking agents. PABA is also used as a biodegradable pesticide, though its use is now limited due to evolution of new variants of bio-pesticides. Specifically, studies have shown that PABA photodegrades through an O2-mediated pathway in which PABA is oxidized by O2 via hydrogen abstraction and decarboxylation. In the past, PABA was widely used in sunscreens as a UV filter. It is a UVB absorber, meaning it can absorb wavelengths between 290 and 320 nm. while still allowing UVA wavelengths between 320-400 nm to pass through, producing a tan. The chemical structure of PABA, with the amino and carboxyl groups being para to each other, allows for easy electron delocalization, which reduces the gap between the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO). This makes it easier for the electrons in PABA to transition to a higher energy state upon absorbing light. Patented in 1943, PABA was one of the first active ingredients to be used in sunscreen. The first in vivo studies on mice showed that PABA reduced UV damage. In addition, it was shown to protect against skin tumors in rodents, as shown by a 1975 study ran by Dr. Diane Sekura Snyder and Dr. Marian May. However, animal and in vitro studies in the early 1980s suggested PABA might increase the risk of cellular UV damage.
Sources: en.wikipedia.org
In this case, the three substrates of this enzyme are cyanidin, reduced nicotinamide adenine dinucleotide phosphate (NADPH), and a proton. It converts them to (–)-epicatechin and oxidised NADP+. The enzyme from the legume Medicago truncatula can use nicotinamide adenine dinucleotide as an alternative cofactor. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is flavan-3-ol:NAD(P)+ oxidoreductase. Other names in common use include AtANR, and MtANR. This enzyme participates in flavonoid biosynthesis.
Genetically modified crops are genetically modified plants that are used in agriculture. The first crops developed were used for animal or human food and provide resistance to certain pests, diseases, environmental conditions, spoilage or chemical treatments (e.g. resistance to a herbicide). The second generation of crops aimed to improve the quality, often by altering the nutrient profile. Third generation genetically modified crops could be used for non-food purposes, including the production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.
Psilocybin is present in varying concentrations in over 200 species of Basidiomycota mushrooms. In a 2000 review on the worldwide distribution of hallucinogenic mushrooms, Gastón Guzmán and colleagues considered these to be distributed amongst the following genera: Psilocybe (116 species), Gymnopilus (14), Panaeolus (13), Copelandia (12), Hypholoma (6), Pluteus (6), Inocybe (6), Conocybe (4), Panaeolina (4), Gerronema (2), and Galerina (one species). Guzmán increased his estimate of the number of psilocybin-containing Psilocybe to 144 species in a 2005 review. The majority of these are found in Mexico (53 species), with the remainder distributed in the United States and Canada (22), Europe (16), Asia (15), Africa (4), and Australia and associated islands (19). The diversity of psilocybin mushrooms is reported to have been increased by horizontal transfer of the psilocybin gene cluster between unrelated mushroom species. In general, psilocybin-containing species are dark-spored, gilled mushrooms that grow in meadows and woods of the subtropics and tropics, usually in soils rich in humus and plant debris. Psilocybin mushrooms occur on all continents, but the majority of species are found in subtropical humid forests. Psilocybe species commonly found in the tropics include P. cubensis and P. subcubensis. P. semilanceata—considered by Guzmán to be the world's most widely distributed psilocybin mushroom—is found in Europe, North America, Asia, South America, Australia and New Zealand, but is entirely absent from Mexico.
=== Development === Sam Levinson's adaptation of the Israeli television series Euphoria created by Ron Leshem was renewed for a third season on February 4, 2022. On September 19, HBO CEO Casey Bloys said the series would not end after the third season. Production of the season was set to start in February 2023. The producers were aiming for a late 2023 release. However, according to a Vogue interview with Lexi's actress Maude Apatow, filming was set to start in the second half of 2023. On a podcast, series costume designer Heidi Bivens said that preparations would begin in May 2023, with filming starting in June. The season's production was one of many disrupted by the 2023 Writers Guild of America strike. Co-producer for half the episodes of season 2, Jeremy O. Harris spoke on the impact it had on the season with Variety, "He's not a scab. David Zaslav [Warner Bros. Discovery CEO], make a deal. That's what I'll say about season 3 of Euphoria. Make a deal, David. It's easy. Just come to that table." Pre-production for the third season had begun by December 2023. On March 12, 2024, Sydney Sweeney said in an MTV interview with Josh Horowitz that filming for the third season was due to "start soon". But on March 25, it was reported that shooting was postponed indefinitely amid speculation that the series would not return. On July 12, HBO announced that cast members had signed on for a third season that would aim for a January 2025 start date.
Sources: en.wikipedia.org
=== New owner === On 23 February 2023, Giant's operator Dairy Farm announced that it was exiting the grocery retail market in Malaysia, citing increasing competition. Dairy Farm's grocery business in Malaysia was sold to Macrovalue Sdn Bhd led by Andrew Lim Tatt Keong, a local businessman and entrepreneur. Dairy Farm, however, would still remain the operator of the Cold Storage and Giant franchise in Singapore until 2025, where it will be sold to Macrovalue Pte Ltd in March 2025. Following the acquisition, Macrovalue announced that Giant Hypermarket in both Singapore and Malaysia will be rebranded as Giant Mall as the parent company attempts to attract more foot traffic and cut down losses.
Like the human practice of veganism, vegan dog foods are those formulated with the exclusion of ingredients that contain or were processed with any part of an animal, or any animal byproduct. A 2023 systematic review found no evidence of serious impacts on animal health from vegetarian cat and dog diets; however, the authors noted that the studies suffered from issues such as selection bias, low sample size, and short feeding periods and recommended further research. The omnivorous domestic canine has evolved to metabolize carbohydrates and thrive on a diet lower in protein, and a vegan diet may be adequate if properly formulated and balanced. Popularity of this diet has grown with a corresponding increase in people practicing vegetarianism and veganism as well as with growing concerns about environmental issues such as climate change or awareness of the large environmental impacts of animal agriculture. Vegetarian dog foods are produced to either assuage a pet owner's ethical concerns or for animals with extreme allergies. Due to the exclusion of animal products and by-products, which are primary ingredients of conventional dog food, many nutrients that would otherwise be provided by animal products need to be provided by replacement, plant-based ingredients. While both animal and plant products offer a wide range of macro and micronutrients, strategic formulation of plant ingredients should be considered to meet nutritional requirements, as different nutrients are more abundant in different plant sources.
The battle at Qalabane demoralized the Cape Mounted Yeomanry, which had previously successfully repulsed much larger bodies of enemy troops, but the Basuto hailed the clash as a great victory. Clarke reached Mafeteng, engaging in counter-insurgency operations in its vicinity until the end of the month before returning to the Cape.
However, in 2015 a study building on earlier research found that happiness has no effect on mortality. "This "basic belief that if you're happier you're going to live longer. That's just not true." Consistent results are that "apart from good health, happy people were more likely to be older, not smoke, have fewer educational qualifications, do strenuous exercise, live with a partner, do religious or group activities and sleep for eight hours a night." Happiness does however seem to have a protective impact on immunity. The tendency to experience positive emotions was associated with greater resistance to colds and flu in interventional studies irrespective of other factors such as smoking, drinking, exercise, and sleep. Positive emotional states have a favorable effect on mortality and survival in both healthy and diseased populations. Even at the same level of smoking, drinking, exercise, and sleep, happier people seem to live longer. Interventional trials conducted to establish a cause-effect relationship indicate positive emotions to be associated with greater resistance to objectively verifiable colds and flu.
There are hundreds of perennial viola and violetta cultivars; many of these do not breed true from seed and therefore have to be propagated from cuttings. Violettas can be distinguished from violas by the lack of ray markings on their petals. The following cultivars, of mixed or uncertain parentage, have gained the Royal Horticultural Society's Award of Garden Merit:
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.